India  

Central Drug Research Institute

Central Drug Research Institute    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Central Drug Research Institute:
The Central Drug Research Institute is a multidisciplinary research laboratory in Lucknow, India, employing scientific personnel from various areas of biomedical sciences. Dr. Radha Rangarajan, An alumnus of Stanford University, University of Michigan, and Rockefeller University,She has been a postdoctoral fellow at Harvard School of Public Health, is the incumbent director of the Central Drug Research Institute.

0
shares
ShareTweetSavePostSend
 

You Might Like


Brain behind India's first oral contraceptive dies

Dr Nitya Anand, the former director of the Central Drug Research Institute (CDRI) and the discoverer of India's first oral contraceptive 'Saheli,' passed away at the age of 99 after a prolonged..
IndiaTimes - Published

Cop28: CDRI launches a platform to estimate risks with respect to climate related hazards

The Coalition for Disaster Resilient Infrastructure (CDRI) has launched a data platform called the Global Infrastructure Risk Model and Resilience Index (GIRI) in Dubai. GIRI is the world's first..
IndiaTimes - Published

No more imported dye for Covid RT-PCR test kit as CDRI develops desi β€˜GreenR’

India's CSIR-Central Drug Research Institute has developed a locally-made DNA Gel stain called 'GreenR', eliminating the need to import the dye used in RT-PCR tests for Covid-19 detection. The..
IndiaTimes - Published

CDRI inks deal with govt; to be global, independent body


IndiaTimes - Published

Quad to work with CDRI to cut disaster risk in Indo-Pacific

The New Delhi-based Coalition for Disaster Resilient Infrastructure (CDRI) has assumed significance in the Quad architecture with a White House statement asserting that the four-nation grouping will..
IndiaTimes - Published

Quad's DRR focus in Indo-Pacific to align with CDRI


IndiaTimes - Published

India welcomes active participation of SACEP countries in CDRI: Yadav


IndiaTimes - Published

20-year-old anti-viral drug works in mild Covid cases: CDRI


IndiaTimes - Published

CDRI achieves breakthrough in trial of Umifenovir in Covid-19 treatment


IndiaTimes - Published